Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |
mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.0004 | 1 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.00026 | 1 |
mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.00023 | 1 |
mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.00023 | 1 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.00014 | 1 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 4.8e-05 | 1 |